MORPHASOL 4 MG/ML SOLUTION FOR INJECTION FOR DOGS AND CATS
Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Характеристики продукта
(SPC)
03-01-2015
Некоторые документы для этого продукта в настоящее время недоступны, вы можете отправить запрос в нашу службу поддержки, и мы сообщим вам, как только мы сможем их получить.
Послать запрос.
Послать запрос.
Активный ингредиент:
BUTORPHANOL TARTRATE
Доступна с:
aniMedica GmbH
код АТС:
QN02AF01
ИНН (Международная Имя):
BUTORPHANOL TARTRATE
дозировка:
4 Mg/Ml
Фармацевтическая форма:
Solution for Injection
Тип рецепта:
POM
Терапевтическая группа:
Canine, Feline
Терапевтические области:
Butorphanol
Терапевтические показания :
Neurological Preparations
Статус Авторизация:
Authorised
Дата Авторизация:
2009-12-18
Характеристики продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Morphasol 4 mg/ml solution for injection for dogs and cats.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substance
Butorphanol
4 mg
(as Butorphanol tartrate 5.83 mg)
Excipients
Benzethonium chloride
0.1 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for Injection.
A clear, colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
DOGS:
As an analgesic: for the relief of mild to moderate visceral pain.
As a sedative: in combination with medetomidine.
CATS:
As an analgesic: for the relief of mild to moderate visceral pain.
4.3 CONTRAINDICATIONS
Do not use in case of known hypersensitivity to the active substance or to any of the excipients in the product.
Do not use in animals with known or suspected liver or kidney disease.
Use of butorphanol is contraindicated in case of cerebral injury or organic brain lesions and in animals with obstructive
respiratory diseases, heart dysfunction or spastic conditions.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 19/12/2014_
_CRN 7019497_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Butorphanol is intended for use where short (dog) and short to medium (cat) analgesia is required. For information on
the duration of analgesia that can be expected following treatment, see section 5.1.
However, repeat treatments of butorphanol may be administered. For cases where longer duration analgesia is likely to
be required, an alternative therapeutic agent should be used.
The safety of the product in young puppies and kittens has
Прочитать полный документ
